Dr Ibáñez and Dr Arruga will attend the 11th Symposium on Controversies in Ophthalmology

Dr Ibáñez and Dr Arruga will attend the 11th Symposium on Controversies in Ophthalmology

Dr Núria Ibáñez, responsible for the Department of Orbit and Oculoplasty at Institut Català de Retina, will attend on 19th February the IX Symposium on Controversies in Ophthalmology, chaired by Dr Jordi Arruga, Head of ICR Department of Neurophthalmology and by Dr. Manel Quintana.

The symposium’s 11th edition will be held at Hospital Universitari de Bellvitge and will gather professionals in Ophthalmology from all over Spain, with the aim of debating innovative subjects within the area of Medical and Surgical Diagnostic of Eye Diseases.

The symposium will begin with an opening ceremony at 8:45 h lead by Dr Rafael Máñez. The morning session will deal with subjects such as Anophthalmic cavities: the use of surgical pearls and management of orbital volume, as well as Postoperative management and complications in filtering surgery.

Dr Ibáñez will participate in the round table held at 13:30 h at the beginning of afternoon’s session which will deal with Guidance to diagnosis and therapeutic management in palpebral malposition. The round table will be chaired by Dr. Maravilla Abias.

The last round table will address the different kinds of glaucoma surgeries and which one to choose. The event will come to an end around 16:30 with the closing ceremony.

Publish you comment

Your email address will not be published

ICR Ganduxer Headquarters

c/Ganduxer,117
08022 Barcelona

ICR Pau Alcover

C. Pau Alcover 67
08017 Barcelona

ICR Terrassa

C/ Sant Pere, 46 2n pis
08221 Terrassa

Clínica Bonanova Surgical Center

Passeig Bonanova, 22
08022 Barcelona

Clinica Bonanova Tests and Treatments

c/ Mandri, 63
08022 Barcelona

ICR Service at Clínica Ntra. Sra. del Remei

c/ de l'Escorial,148
08024 Barcelona
This website uses cookies in order to collect statistical information regarding navigation. If you keep on surfing this website, it shall be deemed to have acknowledged its use. More information.